Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations

Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations

Allan H Young,1 Mohamed Abdelghani,2 Mario F Juruena,1,3 Viktoriya L Nikolova,1 Ramin Nilforooshan4,5 1Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK; 2Camden and Islington NHS Foundation Trust, London, UK; 3Maudsley Advanced Treatment Service (MATS), South L...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Young AH, Abdelghani M, Juruena MF, Nikolova VL, Nilforooshan R
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Dove Medical Press 2023-02-01
Sraith:Neuropsychiatric Disease and Treatment
Ábhair:
depression
trd
mdd
antidepressant
glutamate
Rochtain ar líne:https://www.dovepress.com/early-clinical-experiences-of-esketamine-nasal-spray-in-the-uk-in-adul-peer-reviewed-fulltext-article-NDT

Ar líne

https://www.dovepress.com/early-clinical-experiences-of-esketamine-nasal-spray-in-the-uk-in-adul-peer-reviewed-fulltext-article-NDT

Míreanna comhchosúla